[haematologica reports] 2006;2(13):93-94 J.M.VOSE

Chemotherapy for peripheral T-cell lymphoma Over the past two decades,increased understanding ofthe immune system and genet-ic abnormalities associated with non-Hodgkin’s lymphoma (NHL) have led to the identification of several previous-ly unrecognized types of lymphoma including a variety of T-cell lym-phomas.1-5 This recognition of clinical-ly relevant subtypes led to a proposal for changing the lymphoma classifica-tion which incorporated some aspects of the Kiel classification6 and theWork-ing Formulation.7 Eventually theWorld HealthOrganization (WHO) classifica